United Kingdom Epigenetics Market Size, Share, and COVID-19 Impact Analysis, By Product (Instruments, Reagents & Kits, Enzymes, Software, and Service), By Applications (Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases, Cardiovascular Diseases, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Organizations (CROs), and Others), and United Kingdom Epigenetics Market Insights, Industry Trend, Forecasts to 2033

United Kingdom Epigenetics Market Insights Forecasts to 2033

• The U.K. Epigenetics Market Size was valued at USD 143.5 Million in 2023.
• The U.K. Epigenetics Market Size is Growing at a CAGR of 16.44% from 2023 to 2033
• The U.K. Epigenetics Market Size is expected to exceed USD 657.5 Million by 2033

The United Kingdom Epigenetics Market Size is anticipated to exceed USD 657.5 Million by 2033, growing at a CAGR of 16.44% from 2023 to 2033. The growing prevalence of chronic diseases, demand for personalized medicine, and investment in R&D activities are driving the growth of the epigenetics market in the UK.     

Market Overview

Epigenetics market refers to the products, services, and research that are related to epigenetic studies, examining heritable changes in gene expression without altering the DNA sequence. Epigenetics is the study of heritable traits, or a stable change of cell function, that happen without changes to the DNA sequence. The increasing cases of chronic diseases including CVDs, cancer, neurodegenerative conditions, etc. due to unhealthy diets and sedentary lifestyles, drive the epigenetics market. Furthermore, the advancement in epigenetic research owing to the supportive government initiatives and strong healthcare infrastructure are promoting the epigenetic market. The expanding application of epigenetics and integration of artificial intelligence and machine learning are offering lucrative market growth opportunities for epigenetics.

Report Coverage

This research report categorizes the market for the UK epigenetics market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom epigenetics market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the UK epigenetics market.

Driving Factors

The growing prevalence of chronic diseases is driving the demand for epigenetics for studying the inflammatory disease pathogenesis is driving the epigenetics market. The demand for personalized medicine which requires epigenetics for investigating the heritable changes in gene expression is propelling the market for epigenetics. The growing investment in research & development activities for understanding gene regulation and its applications in disease research and personalized medicine is propelling the market growth.

Restraining Factors

The ethical consideration regarding the use of advanced technologies for gene editing is impeding market growth. The strict regulatory guidelines that cause potential delays in the approval and commercialization of new therapies are challenging the market.

Market Segmentation

The United Kingdom epigenetics market share is classified into product, applications, and end-user.

• The reagents & kits segment dominated the United Kingdom epigenetics market and is expected to grow at a significant CAGR during the projected period.

The United Kingdom epigenetics market is segmented by product into instruments, reagents & kits, enzymes, software, and service. Among these, the reagents & kits segment dominated the United Kingdom epigenetics market and is expected to grow at a significant CAGR during the projected period. Epigenetic reagents & kits are used for the analysis of DNA methylation, histone modification, and RNA transcription supporting epigenetic research.

• The oncology segment is expected to hold the largest market share of the epigenetics market and is anticipated to grow at a significant CAGR during the projected period.

The United Kingdom epigenetics market is segmented by applications into oncology, autoimmune diseases, metabolic diseases, CNS/pain diseases, cardiovascular diseases, and others. Among these, the oncology segment is expected to hold the largest market share of the epigenetics market and is anticipated to grow at a significant CAGR during the projected period. Epigenetics plays a crucial role in cancer development, diagnosis, and treatment. It also approaches personalized and targeted therapies.

• The pharmaceutical & biotechnology companies segment held the largest market share in 2023 and is anticipated to grow at a significant CAGR during the projected period.

The United Kingdom epigenetics market is segmented by end-user into pharmaceutical & biotechnology companies, academic & research organizations (CROs), and others. Among these, the pharmaceutical & biotechnology companies segment held the largest market share in 2023 and is anticipated to grow at a significant CAGR during the projected period. Epigenetics aids in the development of targeted therapies and diagnostics for various diseases like cancer in the pharmaceutical sector.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the U.K. epigenetics market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Illumina Inc
• Abcam Plc
• Active Motif Inc
• Agilent Technologies Inc
• Hologic Inc
• Zymo Research
• Merck Millipore
• PerkinElmer Inc
• QIAGEN NV
• Thermo Fisher Scientific Inc
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In July 2023, Scientists at Edinburgh University have been awarded more than £40m for work which would include research into the lesser known areas of DNA. The Medical Research Council (MRC) has awarded £46.3 million to the MRC Human Genetics Unit at Edinburgh University.

Market Segment

This study forecasts revenue at U.K., regional, and country levels from 2020 to 2033. Spherical Insights has segmented the United Kingdom Epigenetics Market based on the below-mentioned segments:

UK Epigenetics Market, By Product

• Instruments
• Reagents & Kits
• Enzymes
• Software
• Service

UK Epigenetics Market, By Applications

• Oncology
• Autoimmune Diseases
• Metabolic Diseases
• CNS/Pain Diseases
• Cardiovascular Diseases
• Others

UK Epigenetics Market, By End-User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Organizations (CROs)
• Others